1. Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells
   Yingchun Qu et al, 2017 CrossRef
2. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation
   Na Qu et al, 2019, BioMed Eng OnLine CrossRef
3. A microemulsion co-loaded with Schizandrin A–docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance
   Xiangyu Su et al, 2017, Drug Delivery CrossRef
4. Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach
   Wan Sun et al, 2017, The Journal of Clinical Pharmacology CrossRef
5. Optimization of clinical dosing schedule to manage neutropenia: learnings from semi-mechanistic modeling simulation approach
   Yue Guo et al, 2019, J Pharmacokinet Pharmacodyn CrossRef
6. In�vitro study on reversal of ovarian cancer cell resistance to cisplatin by naringin via the nuclear factor-κB signaling pathway
   Hong Zhu et al, 2018, Exp Ther Med CrossRef
7. Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells
   Changcheng Wang et al, 2021, Bioengineered CrossRef
8. Self-triggered impulsive control of nonlinear time delay systems: Application to chemotherapeutic dose-regimen design
   A. Aghaeeyan et al, 2021, Nonlinear Analysis: Hybrid Systems CrossRef